Grace Therapeutics Inc. (GRCE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Grace Therapeutics Inc.

    NASDAQ: GRCE · Real-Time Price · USD
    3.10
    0.02 (0.65%)
    At close: Sep 26, 2025, 3:59 PM
    3.09
    -0.16%
    After-hours: Sep 26, 2025, 07:22 PM EDT

    Grace Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Cash & Equivalents
    		 22.13M 23M 27.88M 30.34M 50.94M
    Short-Term Investments
    		 n/a n/a 15K 13.32M 9.79M
    Long-Term Investments
    		 n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a n/a
    Receivables
    		 126K 722K 802K 548K 530K
    Inventory
    		 n/a n/a n/a n/a n/a
    Other Current Assets
    		 n/a n/a n/a 352K 768K
    Total Current Assets
    		 22.71M 24.01M 29.29M 45.28M 62.37M
    Property-Plant & Equipment
    		 15K 24K 567K 565K 86K
    Goodwill & Intangibles
    		 49.27M 49.27M 49.27M 82.77M n/a
    Total Long-Term Assets
    		 49.28M 49.29M 49.83M 83.34M 86K
    Total Assets
    		 71.99M 73.3M 79.12M 128.62M 62.46M
    Account Payables
    		 601K 1.01M 1.24M 1.68M 115K
    Deferred Revenue
    		 n/a n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 75K 104K 86K
    Other Current Liabilities
    		 n/a n/a -75K -104K -86K
    Total Current Liabilities
    		 1.93M 1.68M 3.41M 3.26M 1.58M
    Long-Term Debt
    		 n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 1.14M 4.36M n/a 10K 5.22M
    Total Long-Term Liabilities
    		 3.45M 9.87M 7.76M 17.09M 5.22M
    Total Liabilities
    		 5.38M 11.56M 11.17M 20.35M 6.8M
    Total Debt
    		 n/a n/a 485K 295K 86K
    Book Value
    		 66.61M 61.74M 67.95M 108.27M 55.66M
    Book Value Per Share
    		 5.51 8.30 9.14 17.63 22.53
    Common Stock
    		 1K 261.04M 258.29M 257.99M 197.19M
    Retained Earnings
    		 -220.69M -211.12M -198.27M -155.84M -146.02M
    Comprehensive Income
    		 -6.04M -6.04M -6.04M -6.04M -6.33M
    Shareholders Equity
    		 66.61M 61.74M 67.95M 108.27M 55.66M
    Total Investments
    		 n/a n/a 15K 13.32M 9.79M

    Add to Watchlist